EKF Diagnostics (LON:EKF) Stock Passes Above 200-Day Moving Average of $28.41

EKF Diagnostics Holdings plc (LON:EKF)’s stock price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 28.41 ($0.35) and traded as high as GBX 28.72 ($0.35). EKF Diagnostics shares last traded at GBX 27.80 ($0.34), with a volume of 183,640 shares.

EKF Diagnostics Price Performance

The company has a market cap of £125.23 million, a P/E ratio of 2,760.00 and a beta of 0.58. The company has a fifty day simple moving average of GBX 27.33 and a 200-day simple moving average of GBX 28.41. The company has a debt-to-equity ratio of 6.01, a current ratio of 2.69 and a quick ratio of 1.77.

Insider Activity

In related news, insider Christopher H. B. Mills purchased 100,000 shares of the stock in a transaction dated Friday, March 22nd. The shares were acquired at an average cost of GBX 26 ($0.32) per share, for a total transaction of £26,000 ($32,114.62). 5.11% of the stock is currently owned by corporate insiders.

About EKF Diagnostics

EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T analyzer; Hemo Control, a hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples.